Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: the Chief who wrote (457)	2/20/2001 12:13:11 PM
From: Dan Hamilton	Read Replies (1) \| Respond to of 500

I wonder what sort of forward guidance we'll get on this... World Heart Corporation to hold telephone conference call to announce year end results OTTAWA, CANADA, Feb 20, 2001 /PRNewswire via COMTEX/ -- World Heart Corporation (WHRT- NASDAQ, WHT- TSE) will hold a telephone conference call for shareholders, media and interested members of the financial community following the release of year- end results for the period ended December 31, 2000. The results will be released via Canada News Wire and PR News at approximately 3:00 p.m. on Thursday February 22, 2001, and will be followed by the conference call at 4:00 p.m. EST. Roderick M. Bryden, President and Chief Executive Officer will host the call. Dr. Tofy Mussivand, Chairman and Chief Scientific Officer and Ian W. Malone, Chief Financial Officer will accompany him. To participate, please call 1-888-740-4844, ten minutes before the call begins. A recording of the presentation and question period will be available for review starting at 6:00 p.m. on February 22, 2001. Investors can access the recording by dialing 1-800-558-5253 and entering the password 17979186. The telephone recording will be available until midnight on March 1, 2001. World Heart Corporation is an Ottawa-based, global medical technology company currently focused on the development and commercialization of pulsatile Ventricular Assist Devices (VAD).